Showing results (411-420 of 3,788) with videos related to
Sort By:
Pageof 379
Oncoimmunology|March 14, 2013
NKG2D ligands link oncogenic RAS to innate immunitySamantha S W Ho, Stephan GasserOncoimmunology|March 14, 2013
Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901Steffen Walter, Toni Weinschenk, Carsten Reinhardt, et al.Oncoimmunology|March 14, 2013
Targeting PI3Kδ: One man's meat is another man's poisonMichaela Prchal-Murphy, Eva Maria Putz, Michael Freissmuth, et al.Oncoimmunology|March 14, 2013
Trial watch: Monoclonal antibodies in cancer therapyErika Vacchelli, Alexander Eggermont, Jérôme Galon, et al.Oncoimmunology|March 14, 2013
Establishing the role of tyrosine kinase 2 in cancerCaroline Ubel, Stephanie Mousset, Denis Trufa, et al.Oncoimmunology|March 14, 2013
Vemurafenib enhances MHC induction in BRAFV600E homozygous melanoma cellsBishu Sapkota, Charles E Hill, Brian P PollackOncoimmunology|March 14, 2013
Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptorsDaniel V Correia, António Lopes, Bruno Silva-SantosOncoimmunology|December 25, 2012
Cardiotrophin-1 determines liver engraftment of syngenic colon carcinoma cells through an immune system-mediated mechanismMatilde Bustos, Juan Dubrot, Eduardo Martinez-Anso, et al.Oncoimmunology|December 25, 2012
HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunityTam Nguyen-Hoai, Dennis Kobelt, Oliver Hohn, et al.Oncoimmunology|December 25, 2012
How do CARs work?: Early insights from recent clinical studies targeting CD19Marco L Davila, Renier Brentjens, Xiuyan Wang, et al.Pageof 379